Financial statements Pharmalink

Balance sheet of Pharmalink

Company age:
Age:
24 y. 4 m. 5 d.
Share capital:
Share capital:
4 000 PLN
Profit and loss statement Balance Cash flow Profitability

Balance sheet data of PHARMALINK

Year
2018
2019
2020
2021
2022
2023
Total assets 29 278 042,58 36 324 310,21 42 323 931,64 45 556 672,41 55 610 755,17 56 833 898,12
A. Fixed assets 3 988 375,03 5 322 935,64 6 114 316,75 7 395 814,40 12 823 720,43 15 300 320,00
B. Current assets 25 289 667,55 31 001 374,57 36 209 614,89 38 160 858,01 42 787 034,74 41 533 578,12
C. Share capital contributions (basic funds) 0,00 0,00 0,00 0,00 0,00 0,00
D. Own shares (stocks) 0,00 0,00 0,00 0,00 0,00 0,00
Total liabilities 29 278 042,58 36 324 310,21 42 323 931,64 45 556 672,41 55 610 755,17 56 833 898,12
A. Equity 12 994 819,42 14 289 502,79 16 715 258,99 19 428 800,77 21 127 579,84 21 531 915,23
B. Liabilities and provisions for liabilities 16 283 223,16 22 034 807,42 25 608 672,65 26 127 871,64 34 483 175,33 35 301 982,89
I. Long-term liabilities 208 944,04 0,00 0,00 1 112 890,39 807 907,15 5 713 505,81
II. Short-term liabilities 15 724 363,76 21 607 466,63 23 496 874,87 21 435 628,88 31 029 184,44 27 216 242,93
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.